(Q77296413)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9736476%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Successes and failures of current treatment of heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9736476%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

J G Cleland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9736476%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

K Swedberg

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9736476%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

P A Poole-Wilson

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9736476%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9736476%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9736476%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

352 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9736476%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

SI19-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9736476%20AND%20SRC:MED&resulttype=core&format=json

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Recognising the limits of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

National trends in the initial hospitalization for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Trends in hospitalization for heart failure in Scotland 1980-1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Severity of heart failure and dosage of angiotensin converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Changing patterns of investigation and treatment of cardiac failure in hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance. European Heart Failure Training Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Withdrawal of long-term diuretic medication in elderly patients: a double blind randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Renal response to candoxatrilat in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Patient characteristics in cases of chronic severe heart failure with different degrees of left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Difference in mortality between patients treated with captopril or enalapril in the xamoterol in severe heart failure study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

The effect of beta adrenergic blockade on patterns of urinary sodium excretion. Studies in normal subjects and in patients with heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Effect of propranolol in myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Development of congestive heart failure after treatment with metoprolol in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Beta-blocking agents in heart failure. Should they be used and how?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

The role of calcium antagonists in the treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Effects of nisoldipine therapy on myocardial perfusion and neuro-hormonal status in patients with severe ischaemic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Amlodipine in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Angiography and the aetiology of heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Diltiazem improves cardiac function and exercise capacity in patients with idiopathic dilated cardiomyopathy. Results of the Diltiazem in Dilated Cardiomyopathy Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Predicting survival after coronary revascularization for ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Mode of death in chronic heart failure. A request and proposition for more accurate classification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Anticoagulant and antiplatelet therapy in heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Ventricular dysfunction and the risk of stroke after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

ACE inhibitors for myocardial infarction: how should they be used?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Effects of enalapril on long-term mortality in severe congestive heart failure. CONSENSUS Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

Measurement of the quality of life in congestive heart failure--influence of drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2990015-0

7 January 2021

10.1016/S0140-6736(98)90015-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9736476%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9736476%20AND%20SRC:MED&resulttype=core&format=json